Discovery of Enzyme Inhibitors from Natural Products
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 53208
Special Issue Editors
Interests: chromatographic analysis; spectroscopic analysis; enzyme immobilizations and applications; preparation and applications of materials with enzyme-like activity
Special Issues, Collections and Topics in MDPI journals
Interests: Lipidomics; metabolomics; Chinese Medicines; Metabolic Diseases; LC/MS
Special Issues, Collections and Topics in MDPI journals
Interests: analytical and bioanalytical chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Enzymes have high catalytic activity, substrate specificity and good biodegradability, which can selectively catalyze a series of biochemical reactions. Inhibition of enzyme activity is considered as a promising approach for treating human diseases. For example, thrombin plays an important role in the processes of thrombosis, and its inhibitors can be used for the treatment of cardiovascular diseases. Glycosidase inhibitors have the potential to be used as drugs for the treatment of diabetes, viral infections, cancers and hereditary lysosomal storage diseases. The inhibition of excessive trypsin activity can be considered as a treatment method for diseases, such as severe acute pancreatitis, fibrosis, hypertension, rheumatoid arthritis and diabetes. Reducing the conversion of xanthine to uric acid by inhibiting the xanthine oxidase activity has become the main approach for the treatment of gout. Tyrosinase inhibitors are potential medicines for the prevention of melanoma and skin tumors.
Natural products are rich sources of new drug discovery, due to their structural diversity. We would like to invite authors to contribute original research and review articles that will stimulate the basic research on the discovery of enzyme inhibitors from natural products. In this Special Issue, we will pay special attention to the manuscripts that evaluate and discuss the screening methods, action mechanisms or expert consensus of natural product-derived enzyme inhibitors. Potential topics suitable for this Special Issue include, but are not limited to:
- Recent advances of discovery of enzyme inhibitors from natural products;
- The use of natural products in the treatment of diseases based on enzyme targets;
- The state-of-the-art technology to discover enzyme inhibitors from natural products;
- SAR studies (structure/activity relationship) of enzyme-targeted natural compounds;
- Natural substances as lead compounds for new drugs in enzyme targeting therapy.
Prof. Dr. Fengqing Yang
Prof. Dr. Jianbo Wan
Dr. Liya Ge
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- enzyme inhibitor
- natural product
- drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Discovery of Enzyme Inhibitors from Natural Products II in Molecules (6 articles)